Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 165

Showing 1-25 of 165 citing articles:

Polyunsaturated Fatty Acids Drive Lipid Peroxidation during Ferroptosis
Michael S. Mortensen, Jimena Ruiz, Jennifer L. Watts
Cells (2023) Vol. 12, Iss. 5, pp. 804-804
Open Access | Times Cited: 100
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Yumin Wang, Yongming Chen, Junjing Zhang, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101018-101018
Open Access | Times Cited: 95
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 45
Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance
Xudong Zhu, Shenglong Li
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 44
Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma
Shi-Hui Hao, Xiaodan Ma, Li Xu, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101052-101052
Closed Access | Times Cited: 20
Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine
Yanhong Su, Bing Liu, Binghan Wang, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 19
Circumventing drug resistance in gastric cancer: A spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics
Gang Che, Jie Yin, Wankun Wang, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101080-101080
Closed Access | Times Cited: 19
Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer
Bowen Li, Zixian Wei, Zhiyue Wang, et al.
Free Radical Biology and Medicine (2024) Vol. 220, pp. 125-138
Open Access | Times Cited: 19
Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11
Zixi Wang, Huaiyuan Zong, Weiwei Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 17
Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA
Shuai-Jun Chen, Jun Zhang, Ting Zhou, et al.
Redox Biology (2023) Vol. 69, pp. 102975-102975
Open Access | Times Cited: 38
Effective targeting of breast cancer by the inhibition of P-glycoprotein mediated removal of toxic lipid peroxidation byproducts from drug tolerant persister cells
Kornélia Szebényi, András Füredi, Eszter Bajtai, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101007-101007
Open Access | Times Cited: 31
Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells
Wenkai Chen, Zongguang Li, Naichun Yu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy
Rui Wang, Wenqin Song, Jie Zhu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 84-96
Closed Access | Times Cited: 14
Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 14
Targeting anoikis resistance as a strategy for cancer therapy
Yumin Wang, Sihang Cheng, Joshua S. Fleishman, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101099-101099
Closed Access | Times Cited: 13
Targeting novel regulated cell death：Ferroptosis, pyroptosis, and autophagy in sepsis-associated encephalopathy
Jingjing Sun, Joshua S. Fleishman, Xueyan Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116453-116453
Open Access | Times Cited: 12
Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
Custom‐Design of Multi‐Stimuli‐Responsive Degradable Silica Nanoparticles for Advanced Cancer‐Specific Chemotherapy
Junjie Zhang, Jiani Zhou, Longguang Tang, et al.
Small (2024) Vol. 20, Iss. 35
Closed Access | Times Cited: 11
Gastric cancer secreted miR-214-3p inhibits the anti-angiogenesis effect of apatinib by suppressing ferroptosis in vascular endothelial cells
W. Wang, Tongtong Wang, YAN ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 489-502
Open Access | Times Cited: 10
ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: Design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation
Furong Ma, Yulong Li, Mao-Hua Cai, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116387-116387
Closed Access | Times Cited: 10
Altered glycosylation in cancer: molecular functions and therapeutic potential
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 10
HIF-1α Induced by Hypoxia Promotes Peripheral Nerve Injury Recovery Through Regulating Ferroptosis in DRG Neuron
Shuai An, Jingfei Shi, Jiang Huang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6300-6311
Closed Access | Times Cited: 9
Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance
Celine Kapper, Peter Oppelt, Barbara Arbeithuber, et al.
Life Sciences (2024) Vol. 349, pp. 122720-122720
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top